ABVC BioPharma, Inc. Contract Liability (Deferred Revenue)
ABVC BioPharma, Inc. (ECOC) had Contract Liability (Deferred Revenue) of $12.60 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Contract with Customer, Liability, Current $12.60K.
- 2026-03-31: Contract with Customer, Liability, Current $12.60K.
- 2025-12-31: Contract with Customer, Liability, Current $12.60K.
- 2025-09-30: Contract with Customer, Liability, Current $81.11K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2026-06-30 | $12.60K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $12.60K 10-Q · filed 2026-05-18 |
| 2025-12-31 | $12.60K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $81.11K 10-Q/A · filed 2026-03-03 |
| 2025-06-30 | $81.11K 10-Q · filed 2025-08-13 |
| 2025-03-31 | $81.11K 10-Q · filed 2025-04-30 |
| 2024-12-31 | $81.11K 10-Q/A · filed 2026-03-03 |
| 2024-09-30 | $79.50K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $79.50K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $79.50K 10-Q · filed 2024-05-17 |
| 2023-12-31 | $79.50K 10-K · filed 2025-04-15 |
| 2023-09-30 | $79.50K 10-Q · filed 2023-11-15 |
| 2022-12-31 | $10.98K 10-K · filed 2024-03-13 |